Performance of Commercially Available Enzyme Immunoassays for Detection of Antibodies against Herpes Simplex Virus Type 2 in African Populations
Open accessThe DOI matches its Crossref record.
Abstract
Data are accumulating on the performance of enzyme immunoassays (EIAs) for the detection of herpes simplex virus type 2 (HSV-2) infection in North America and Europe, but little is known about their performance in other populations. Nine test kits were evaluated with 330 serum samples from sub-Saharan Africa. The tests were first compared to the monoclonal antibody (MAb) EIA (Central Public Health Laboratory, London, United Kingdom). Samples that gave discordant results in the MAb EIA and in the three tests that performed best compared to the MAb EIA were tested by Western blotting (University of Washington, Seattle). A random sample of concordant samples was also tested, and the sensitivities and specificities of the different tests were calculated, taking into account this sampling strategy. The sensitivities of the tests ranged from 86 to 100%; the specificities ranged from 47 to 99%. The tests that performed best were the Gull Premier EIA (sensitivity, 86.3%; specificity, 97.6%) and the Kalon Biological (sensitivity, 92.3%; specificity, 97.7%) and Biokit (sensitivity, 86.7%; specificity, 92.6%) tests. It cannot be assumed that enzyme immunoassays for the detection of HSV-2 infection that perform well in industrialized countries will perform equally well in other populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000198081.09337.a7 · Cited by 1,192
Self-citationReduction of HIV-1 RNA Levels with Therapy to Suppress Herpes Simplex Virus
Nagot, N., Ouédraogo, A., Foulongne, V., Konaté, I., Weiss, H. A., Vergne, L., Defer, M.-C., Djagbaré, D., Sanon, A., Andonaba, J.-B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062607 · Cited by 389
Self-citationWeiss, H. A., Thomas, S. L., Munabi, S. K., & Hayes, R. J. (2006) · Sexually Transmitted Infections · doi:10.1136/sti.2005.017442 · Cited by 382
Self-citationRoss, D. A., Changalucha, J., Obasi, A. I., Todd, J., Plummer, M. L., Cleophas-Mazige, B., Anemona, A., Everett, D., Weiss, H. A., Mabey, D. C., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3282ed3cf5 · Cited by 317
Self-citationTorrone, E. A., Morrison, C. S., Chen, P.-L., Kwok, C., Francis, S. C., Hayes, R. J., Looker, K. J., McCormack, S., McGrath, N., van de Wijgert, J. H. H. M., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002511 · Cited by 256
Self-citation
Metadata
- Authors
- Van Dyck, E., Buvé, A., Weiss, H. A., Glynn, J. R., Brown, D. W. G., De Deken, B., Parry, J., & Hayes, R. J.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2004-07
- Volume
- 42
- Issue
- 7
- Pages
- 2961-2965
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2124258251
- Cited by
- 102
- References
- 0
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Performance of Commercially Available Enzyme Immunoassays for Detection of Antibodies against Herpes Simplex Virus Type 2 in African Populations. https://app.cochat.ai/papers/10.1128/jcm.42.7.2961-2965.2004
- The paper
- Van Dyck, E., Buvé, A., Weiss, H. A., Glynn, J. R., Brown, D. W. G., De Deken, B., Parry, J., & Hayes, R. J. (2004). Performance of Commercially Available Enzyme Immunoassays for Detection of Antibodies against Herpes Simplex Virus Type 2 in African Populations. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.42.7.2961-2965.2004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.